SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-267339 from CONTRAFECT Corp (CFRXQ) (CIK 0001478069)

CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
Date: Oct. 31, 2023 · CIK: 0001478069 · Accession: 0001193125-23-267339

AI Filing Summary & Sentiment

File numbers found in text: 333-275148

Date
October 31, 2023
Author
CONTRAFECT CORPORATION.
Form
CORRESP
Company
CONTRAFECT Corp (CFRXQ) (CIK 0001478069)

Letter

CONTRAFECT CORPORATION

28 Wells Avenue, Third Floor

Yonkers, New York 10701

October 31, 2023

VIA EDGAR TRANSMISSION

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention:

Joshua Gorsky

Re:

CONTRAFECT CORPORATION

Registration Statement on Form S-1 (Registration No. 333-275148)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (Registration No. 333- 275148) (as amended, the “Registration Statement”) of ContraFect Corporation (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on November 2, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027.

If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration.

Very truly yours,
CONTRAFECT CORPORATION.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 CONTRAFECT CORPORATION

28 Wells Avenue, Third Floor

Yonkers, New York 10701

 October 31, 2023

 VIA EDGAR TRANSMISSION

Securities and Exchange Commission

 Division of Corporation
Finance

 Office of Life Sciences

 100 F Street, N.E.

Washington, D.C. 20549

Attention:

Joshua Gorsky

 Re:

CONTRAFECT CORPORATION

Registration Statement on Form S-1 (Registration No. 333-275148)

 Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the
Registration Statement on Form S-1 (Registration No. 333- 275148) (as amended, the “Registration Statement”) of ContraFect Corporation (the
“Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on November 2, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the
staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley
Holmes at (617) 948-6027.

 If you have any questions regarding the foregoing, please do not
hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration.

Very truly yours,

CONTRAFECT CORPORATION.

By:

 /s/ Michael Messinger

Name:

Michael Messinger

Title:

Chief Financial Officer

cc:
 Peter N. Handrinos, Latham & Watkins LLP

Wesley C. Holmes, Latham & Watkins LLP